Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers

Andrew Brenner

Mays Cancer Center

Press/Media: Press / Media

Period	Sep 18 2020 → Sep 20 2020

Media coverage

Title Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet PipelineReview
Country Spain
Date 9/20/20
Persons Andrew Brenner
Title Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet Morningstar.com
Country United States
Date 9/18/20
Persons Andrew Brenner
Title Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet TMC Net
Country United States
Date 9/18/20
Persons Andrew Brenner
Title Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet Forex TV
Country United States
Date 9/18/20
Persons Andrew Brenner
Title Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet StocksNewsFeed.com
Country United States
Date 9/18/20
Persons Andrew Brenner
Title Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet MarketScreener.com
Country United States
Date 9/18/20
Persons Andrew Brenner
Title Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet Markets Business Insider
Country United States
Date 9/18/20
Persons Andrew Brenner
Title Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet Customer Zone 360.com
Country United States
Date 9/18/20
Persons Andrew Brenner
Title Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet Jotup
Country United States
Date 9/18/20
Persons Andrew Brenner
Title Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet Nasdaq
Country United States
Date 9/18/20
Persons Andrew Brenner
Title Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet Biotechgate
Country Switzerland
Date 9/18/20
Persons Andrew Brenner
Title Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet USA Life Sciences Database
Country Switzerland
Date 9/18/20
Persons Andrew Brenner
Title Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet GlobeNewswire
Country United States
Date 9/18/20
Persons Andrew Brenner
Title Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet EIN Presswire
Country United States
Date 9/18/20
Persons Andrew Brenner
Title Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet BizWire Express
Country India
Date 9/18/20
Persons Andrew Brenner

Title	Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet	PipelineReview
Country	Spain
Date	9/20/20
Persons	Andrew Brenner

Title	Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet	Morningstar.com
Country	United States
Date	9/18/20
Persons	Andrew Brenner

Title	Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet	TMC Net
Country	United States
Date	9/18/20
Persons	Andrew Brenner

Title	Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet	Forex TV
Country	United States
Date	9/18/20
Persons	Andrew Brenner

Title	Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet	StocksNewsFeed.com
Country	United States
Date	9/18/20
Persons	Andrew Brenner

Title	Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet	MarketScreener.com
Country	United States
Date	9/18/20
Persons	Andrew Brenner

Title	Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet	Markets Business Insider
Country	United States
Date	9/18/20
Persons	Andrew Brenner

Title	Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet	Customer Zone 360.com
Country	United States
Date	9/18/20
Persons	Andrew Brenner

Title	Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet	Jotup
Country	United States
Date	9/18/20
Persons	Andrew Brenner

Title	Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet	Nasdaq
Country	United States
Date	9/18/20
Persons	Andrew Brenner

Title	Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet	Biotechgate
Country	Switzerland
Date	9/18/20
Persons	Andrew Brenner

Title	Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet	USA Life Sciences Database
Country	Switzerland
Date	9/18/20
Persons	Andrew Brenner

Title	Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet	GlobeNewswire
Country	United States
Date	9/18/20
Persons	Andrew Brenner

Title	Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet	EIN Presswire
Country	United States
Date	9/18/20
Persons	Andrew Brenner

Title	Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Media name/outlet	BizWire Express
Country	India
Date	9/18/20
Persons	Andrew Brenner

View all 15

View less